Fourth Dose of Pfizer mRNA COVID-19 Vaccine in Residents of Long-Term Care Facilities
Latest Information Update: 06 Jun 2024
At a glance
- Drugs Tozinameran (Primary) ; Pneumococcal 13-valent CRM197 vaccine conjugate
- Indications COVID 2019 infections
- Focus Pharmacodynamics
- 29 Jun 2022 Planned initiation date changed from 1 Jun 2022 to 1 Aug 2022.
- 20 May 2022 The drug candidate Elasomeran - Moderna Therapeutics has been replaced by Pfizer-BioNtech mRNA- COVID-19 vaccine.
- 20 May 2022 Planned End Date changed from 15 Apr 2022 to 31 Dec 2022.